Core Insights - Diamondback Energy (FANG) is scheduled to report its third-quarter 2025 results on November 3, with an expected earnings per share (EPS) of $2.79 and revenues of $3.4 billion [1][9] Group 1: Previous Performance - In the second quarter, Diamondback reported adjusted EPS of $2.67, exceeding the Zacks Consensus Estimate of $2.63, with revenues of $3.7 billion, surpassing estimates by 11.8% [2] - The company has beaten the Zacks Consensus Estimate in three of the last four quarters, with the most recent estimate for the third quarter revised upward by 2.6%, indicating a year-over-year decline of 17.5% in EPS but a revenue increase of 29.1% [3] Group 2: Operational Factors - Diamondback holds over 850,000 net acres in the Delaware and Midland regions, with nearly 9,600 drilling locations and production exceeding 900,000 barrels of oil equivalent per day [4] - The recent $26 billion acquisition of Endeavor Energy enhances Diamondback's position in the Permian Basin, providing access to high-quality acreage and lower production costs [5] - The company is expected to benefit from increased production in the third quarter, with an average volume forecasted at 904,988.8 BOE/d, reflecting a 58.5% increase from the previous year's level of 571,098 BOE/d [6] Group 3: Earnings Outlook - The company's earnings model suggests a likely earnings beat, supported by a positive Earnings ESP of +4.26% and a Zacks Rank of 3 [7]

Core Insights - Baxter International Inc. (BAX) is set to release its third-quarter 2025 results on October 30, with expectations of modest growth despite recent mixed performance [1][3] Q3 Estimates - The consensus estimate for revenues is $2.87 billion, reflecting a 6.4% increase from the prior-year quarter [2] - Earnings per share (EPS) is projected at 60 cents, indicating a 25% year-over-year decline [2] Important Factors to Note - The company experienced a 4% growth in sales from continuing operations in the second quarter, supported by Drug Compounding, Advanced Surgery, and Care & Connectivity Solutions, but faced challenges in Infusion Therapies & Technologies and Injectables & Anesthesia [3] - Adjusted EPS for the second quarter was 59 cents, at the low end of guidance, while operating margin improved by 180 basis points to 15.1% [3] Management Expectations - For Q3, management anticipates revenue growth of 6-7% and operational growth of 3-4%, aided by foreign exchange tailwinds and approximately $80 million in MSA revenues from Vantive [4] - Adjusted EPS is expected to range between 58-62 cents, with margin stability anticipated despite volume pressures in IV solutions [4] Segmental Overview - **Medical Products & Therapies (MPT)**: Second-quarter sales rose 1% operationally to $1.3 billion, with Advanced Surgery growth offset by weakness in ITT [6] - **Healthcare Systems & Technologies (HST)**: Revenues increased 2% to $767 million, driven by 4% growth in CCS, with international strength [9] - **Pharmaceuticals**: Sales grew 1% to $612 million, with Drug Compounding growth offsetting declines in Injectables and anesthesia [10] - **Other Sales & Transitional Revenues**: Other sales totaled $13 million, with MSA revenues from Vantive contributing $98 million; projected MSA revenues for Q3 are nearly $80 million [11] Earnings Prediction Insights - The current model does not predict an earnings beat for Baxter, as the Earnings ESP is 0.00% [12] - Baxter holds a Zacks Rank of 3, indicating a hold position [13]

Core Insights - Enterprise Products Partners LP (EPD) is scheduled to report its third-quarter 2025 results on October 30, with earnings estimated at 67 cents per share, reflecting a 3.1% year-over-year increase, while revenues are expected to decline by 9% to $12.6 billion [1][5]. Earnings Performance - EPD has beaten consensus earnings estimates in two of the last four quarters, with an average surprise of 0.01% [2]. - The current Earnings ESP for EPD is -0.75%, and it holds a Zacks Rank of 4 (Sell), indicating a lower likelihood of an earnings beat this time [3]. Operational Factors - EPD operates a pipeline network exceeding 50,000 miles and has over 300 million barrels of liquids storage capacity, which is expected to generate stable fee-based revenues [4]. - The Gross operating margin from the Natural Gas Pipelines & Services segment is estimated at $402.33 million, up from $349 million a year ago [6]. Market Performance - EPD's stock has increased by 14.8% over the past year, outperforming the industry average of 2.9% [7]. - The current trailing 12-month EV/EBITDA ratio for EPD is 10.08, which is lower than the industry average of 10.44, suggesting it is undervalued [10]. Commodity Dependence - EPD relies heavily on the Permian Basin for its operations, which is experiencing a shift towards natural gas production as core oil-producing regions are depleting [12]. - This shift may pressure EPD's profit margins, as natural gas and NGLs are generally less profitable than oil [13]. Comparison with Peers - Enbridge (ENB) is set to report earnings on November 7, 2025, with an Earnings ESP of -7.36% and a Zacks Rank of 3 [14]. - Kinder Morgan Inc. (KMI) reported third-quarter earnings of 29 cents per share, meeting estimates, with total revenues of $4.15 billion, surpassing expectations [15][16].

Core Insights - AbbVie is expected to report Q3 2025 earnings on October 31, with sales estimated at $15.59 billion and earnings per share (EPS) at $1.80, although earnings estimates have declined from $12.02 to $10.81 in the past month [1][4][20] Financial Performance - AbbVie has consistently exceeded earnings expectations in the last four quarters, with an average earnings surprise of 2.46% [2][3] - The company anticipates adjusted earnings between $1.74 and $1.78 per share for Q3 2025, with net revenues around $15.5 billion [6] Product Performance - Sales growth is expected to be driven by newer immunology drugs, Skyrizi and Rinvoq, with consensus estimates for Skyrizi at $4.56 billion and Rinvoq at $2.16 billion [7] - Humira, AbbVie's blockbuster drug, is projected to generate $1.15 billion in sales, facing erosion due to lost patent protection [8] - In oncology, sales of Imbruvica are expected to decline due to competition, while Venclexta sales are anticipated to rise [9][10] - Neuroscience product sales are estimated at $2.74 billion, driven by strong performances from Botox, Vraylar, and new migraine drugs [12][11] - Aesthetics product sales are projected to recover to $1.27 billion, supported by stabilizing demand in the U.S. market [13] Stock Performance and Valuation - AbbVie's stock has increased over 28% this year, outperforming the industry and S&P 500 [15] - The stock is trading at a P/E ratio of 16.60, above the industry average of 15.58 and its five-year mean of 13.27 [18] Strategic Outlook - AbbVie is expected to achieve robust revenue growth in 2025, with a projected high single-digit revenue CAGR through 2029, driven by Skyrizi and Rinvoq [20] - Recent acquisitions and licensing deals have increased near-term expenses, impacting EPS estimates negatively [22][23] - Short-term investors may consider selling due to elevated IPR&D expenses, while long-term investors may remain optimistic about the company's growth potential [24]

Core Insights - Xcel Energy (XEL) is set to announce its third-quarter 2025 results on October 30, with a previous earnings surprise of 19.05% [1] Factors Impacting Q3 Earnings - Cost management initiatives and efficiency programs have resulted in lower residential electric and natural gas bills compared to the national average, attracting new customers [2] - The increase in demand from new customers is expected to positively influence revenue performance for the quarter [2] - Growing demand from data centers, rising electric vehicle adoption, and economic expansion in service regions are likely to boost quarterly earnings [3] - However, higher operating and maintenance expenses may offset some gains, and severe storms in July that damaged infrastructure in Minnesota and South Dakota are expected to negatively impact earnings [3] Q3 Expectations - The Zacks Consensus Estimate for earnings is $1.31 per share, reflecting a year-over-year increase of 4.8% [4] - Revenue is estimated at $3.94 billion, indicating an 8.1% increase from the previous year [4] Earnings Prediction - The company's Earnings ESP is +0.38%, suggesting a potential earnings beat [5] - Xcel Energy currently holds a Zacks Rank of 3 (Hold) [6] Other Industry Players - NiSource Inc. (NI) is expected to report on October 29, with an earnings estimate of 19 cents per share and a long-term growth rate of 7.22% [7][8] - Eversource Energy (ES) will report on November 4, with an earnings estimate of $1.12 per share and a long-term growth rate of 5.86% [8] - Duke Energy (DUK) is scheduled for November 7, with an earnings estimate of $1.73 per share and a long-term growth rate of 6.43% [9]

Core Insights - VICI Properties Inc. is expected to report third-quarter 2025 earnings on October 30, with anticipated growth in revenues and adjusted funds from operations (AFFO) per share [1][8] - The company reported an AFFO per share of 60 cents in the last quarter, aligning with the Zacks Consensus Estimate [1] Financial Performance - Over the last four quarters, VICI's AFFO per share exceeded the Zacks Consensus Estimate once and met expectations in the other quarters, with an average surprise of 0.45% [2] - The Zacks Consensus Estimate for quarterly revenues is $1.00 billion, indicating a growth of 3.99% from the previous year's quarter [3] - Income from sales-type leases is estimated at $530.52 million, up from $518.69 million year-over-year [4] - Income from lease financing receivables and loans is projected at $439.41 million, an increase from $419.12 million in the prior year [4] - Revenues from golf operations are expected to reach $8.49 million, up from $7.55 million in the year-ago period [4] - The consensus for other income stands at $19.51 million, slightly up from $19.32 million in the previous year [5] Growth Drivers - VICI's performance is likely supported by strong partnerships with top-tier experiential operators and stable revenue generation from long-term triple-net leases [2][8] - The company has diversified its portfolio beyond gaming, including investments in non-gaming experiential assets like Chelsea Piers and Bowlero, which contributes to revenue growth [3][8] Earnings Predictions - The Zacks Consensus Estimate for quarterly AFFO per share has remained unchanged at 59 cents for over three months, indicating a growth of 3.51% from the year-ago quarter [5] - The current Earnings ESP for VICI Properties is 0.00%, with a Zacks Rank of 2, suggesting a lack of definitive prediction for a surprise in AFFO per share this quarter [6][7]

Core Insights - Rithm Capital Corp. (RITM) is scheduled to report its third-quarter 2025 results on October 30, 2025, with earnings estimated at 54 cents per share and revenues of $1 billion [1][5]. Earnings Estimates - The earnings estimate for the third quarter has increased by 2 cents over the past 60 days, remaining consistent with the previous year's level [2]. - The Zacks Consensus Estimate for quarterly revenues indicates a significant year-over-year increase of 61.5% [2]. Full-Year Projections - For the full year 2025, the revenue estimate for Rithm Capital is projected at $4.3 billion, reflecting a year-over-year decrease of 17.9% [3]. - The consensus estimate for the current year's EPS is $2.15, suggesting a modest growth of 2.4% year-over-year [3]. Recent Performance - Rithm Capital has consistently beaten consensus estimates in the last four quarters, with an average surprise of 20.1% [3]. Earnings Prediction Model - The current model does not predict a definitive earnings beat for RITM, as it has an Earnings ESP of 0.00% and a Zacks Rank of 2 (Buy) [4]. Revenue Breakdown - The consensus estimate for asset management revenues is $92.2 million, representing a year-over-year increase of 13.8% [5]. - Net servicing revenues are expected to reach $413.9 million, indicating substantial improvement from the previous year [5][6]. Cost Considerations - Increased general and administrative costs, along with lower interest income, may pressure overall profitability [5][7]. - The Zacks Consensus Estimate for interest income shows an anticipated decline of 11.9% year-over-year [7]. Strategic Factors - The profitability of Rithm Capital's Newrez business is expected to positively impact its Origination & Servicing segment [6]. - Strategic partnerships and a diversified platform are anticipated to support third-quarter results [6]. Comparison with Peers - While an earnings beat for Rithm Capital appears uncertain, other companies in the finance sector, such as Franklin Resources, Ameriprise Financial, and Brookfield Corporation, show potential for earnings beats based on their respective Earnings ESPs and Zacks Ranks [8][9][10][11].

Core Insights - Methanex Corporation (MEOH) is scheduled to release its third-quarter 2025 results on October 29, with expectations of benefiting from higher methanol volumes despite facing challenges from lower prices [1][7] - The company has consistently surpassed the Zacks Consensus Estimate in the past four quarters, averaging an earnings surprise of approximately 83.2%, with a notable 130.9% surprise in the last quarter [1] Revenue Estimates - The Zacks Consensus Estimate for Methanex's third-quarter consolidated revenues is currently $974 million, reflecting a year-over-year increase of 4.2% [4] Performance Factors - Methanex's third-quarter performance is anticipated to be positively influenced by increased methanol sales volumes, driven by a 4% rise in global methanol demand in the second quarter, particularly in China [5] - However, weaker methanol prices are expected to negatively impact the company's results, with the average realized price for methanol projected to decline to $345 per ton, a 3% year-over-year decrease from the previous quarter's $374 per ton [8] Earnings Prediction - The current model does not predict a definitive earnings beat for Methanex this quarter, as it holds a Zacks Rank of 5 (Strong Sell), despite an Earnings ESP of +22.53% [9][10]

Core Insights - Old Dominion Freight Line (ODFL) is set to report its third-quarter 2025 results on October 29, before market open, with a history of earnings surprises [1] - The company has outperformed the Zacks Consensus Estimate in two of the last four quarters, with an average earnings surprise of 1.77% [1][2] Earnings Performance - The Zacks Consensus Estimate for ODFL's Q3 2025 earnings per share is $1.22, reflecting a 14.69% decline year over year and a downward revision of 0.81% in the past 60 days [4][6] - Q3 revenue is projected at $1.40 billion, indicating a 4.79% decrease from the previous year, attributed to weak freight demand and inflationary pressures [6][7] Revenue Breakdown - Revenue from Less-Than-Truckload (LTL) services is expected to be $1.39 billion, a decline of 3.9%, while other services are forecasted to generate $14.2 million, an increase of 8.7% year over year [8] Earnings Prediction Model - The current model does not predict an earnings beat for ODFL, as it holds a Zacks Rank of 4 (Sell) and an Earnings ESP of +0.67% [9]

Core Insights - InterDigital, Inc. (IDCC) is expected to report third-quarter 2025 results on October 30, with adjusted earnings of $6.52 per share in the last quarter [1] - The company is projected to experience revenue growth year over year, driven by strong demand in the smartphone market, holding licenses for 85% of the global smartphone market [1] Factors at Play - InterDigital is actively pursuing agreements with unlicensed customers in the handset and consumer electronics sectors, aiming to be a leading designer and developer in mobile technology and IoT [2] - The company has secured a new patent license agreement with Samsung Electronics and a leading Chinese smartphone vendor, now licensing 8 out of the 10 major smartphone players [3] Patent Portfolio and Innovation - InterDigital boasts a portfolio of over 33,000 granted patents and applications, enhancing its presence in consumer electronics and IoT markets [4] - The company is focusing on AI applications for wireless and video technology and collaborating with major academic institutions to accelerate 6G research [4] Overall Expectations - Total recurring revenues are estimated at $139.3 million, reflecting an 8.1% year-over-year growth, with the Zacks Consensus Estimate for revenues at $145 million for the September quarter [5] - The consensus estimate for adjusted earnings per share is $1.79, indicating growth from the previous year's $1.63 [5] Earnings Whispers - The current model does not predict an earnings beat for InterDigital, with an Earnings ESP of 0.00% and both estimates at $2.05 per share [6][7] - InterDigital holds a Zacks Rank of 1, indicating a strong buy [7] Stocks to Consider - InterDigital's new patent agreements with Samsung and a major Chinese vendor enhance its market reach in the smartphone sector [8] - The company's strong patent portfolio and innovation efforts support growth in IoT and AI segments [8]